KRAS and colorectal carcinoma: Treatment with deltarasin led to a rapid organoid dissociation and a highly significant reduction in viability of both Apcfl/fl and KPN organoid lines demonstrating an important role for KRAS4B in maintaining CRC organoid viability (Fig. 5e, f).